ArticleMolecular imaging and biology2025

Correction: Preclinical Development of Near-Infrared-Labeled CD38-Targeted Daratumumab for Optical Imaging of CD38 in Multiple Myeloma.

Nicholas Cho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.